23 Feb 2024 08:00 CET

23 February 2024

The Board of Directors of Norlandia Health & Care Group AS has approved the
unaudited Group financial results for the fourth quarter of 2023. Please find
attached the Q4 2023 Interim Report.

For further information, please contact:
Yngvar Tov Herbjørnssønn (CEO): +47 91 83 71 89
Roger Larsen (CFO): +47 90 63 73 29
Anders Belsvik (Investor Relations): +47 97 76 11 23


611709_NHC Q423 - Financial Report.pdf

Kilde

Norlandia Health & Care Group AS

Leverandør

Oslo Børs Newspoint

Company Name

Norlandia Health AS 21/25 FRN SEK FLOOR C, Norlandia Health AS 21/25 FRN FLOOR C

ISIN

NO0010997943, NO0010997927

Marked

Euronext Oslo Børs